AE group (n = 10) | non-AE group (n = 27) | p value | |
Ages (years) | 74 ± 8 | 71 ± 7 | 0.236 |
Male/Female | 9/1 | 22/5 | 0.903 |
Smoking index | 1080 ± 620 | 957 ± 637 | 0.602 |
Serum markers | |||
WBC(/μl) | 7110 ± 1314 | 6911 ± 1641 | 0.733 |
LDH (IU/l) | 218 ± 56 | 201 ± 52 | 0.381 |
CRP (mg/dl) | 1.0 ± 2.4 | 0.8 ± 1.5 | 0.757 |
KL-6 (U/ml) | 802 ± 549 | 682 ± 299 | 0.449 |
SP-D(ng/ml) | 137 ± 88 | 140 ± 106 | 0.964 |
Pulmonary function test | |||
%VC (%) | 99 ± 22 | 95 ± 17 | 0.571 |
FEV1(L) | 2.2 ± 0.5 | 2.1 ± 0.4 | 0.886 |
FEV1% (%) | 72 ± 11 | 75 ± 10 | 0.501 |
Blood gas analysis | |||
PaO2 (Torr) | 89 ± 14 | 86 ± 9 | 0.358 |
AaDO2 (Torr) | 14 ± 11 | 15 ± 10 | 0.813 |